{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:20:07Z","timestamp":1791091207622,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue de Pneumologie Clinique"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.pneumo.2012.12.003","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T13:31:32Z","timestamp":1358170292000},"page":"26-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prise en charge diagnostique et th\u00e9rapeutique du m\u00e9soth\u00e9liome pleural malin"],"prefix":"10.1016","volume":"69","author":[{"given":"J.","family":"Delourme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Dhalluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Cortot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-J.","family":"Lafitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Scherpereel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneumo.2012.12.003_bib0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1183\/09031936.00146810","article-title":"Thoracic oncology in Europe: the ERS action plan by the Thoracic Oncology Assembly","volume":"36","author":"Sculier","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0010","doi-asserted-by":"crossref","first-page":"492608","DOI":"10.1155\/2012\/492608","article-title":"Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis","volume":"2012","author":"Matsuzaki","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0015","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0761-8425(06)71779-X","article-title":"La conf\u00e9rence d\u2019experts de la Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise (SPLF) sur le m\u00e9soth\u00e9liome pleural malin (MPM)\u00a0: des recommandations utiles et n\u00e9cessaires","volume":"23","author":"Scherpereel","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0025","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1378\/chest.122.6.2224","article-title":"Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area","volume":"122","author":"Metintas","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0030","first-page":"523","article-title":"A multicenter evaluation of assays for detection of SV40\u00a0DNA and results in masked mesothelioma specimens","volume":"10","author":"Strickler","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0035","first-page":"4505","article-title":"A multiinstitutional study confirms the presence and expression of simian virus 40\u00a0in human malignant mesotheliomas","volume":"58","author":"Testa","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0040","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1200\/JCO.2005.03.7101","article-title":"Is there a role for SV40\u00a0in human cancer?","volume":"24","author":"Poulin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0045","first-page":"705","article-title":"Family mesotheliomas: genetic interaction with environmental carcinogenic exposure?","volume":"94","author":"You","year":"2007","journal-title":"Bull Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0050","unstructured":"Kalogeraki AM, Tamiolakis DJ, Lagoudaki ED, Papadakis MN, Papadakis GZ, Agelaki SI, et al. Familial mesothelioma in first degree relatives. Diagnostic Cytopathology [Internet] 2012 [cit\u00e9 2012\u00a0avr 21]\u00a0; disponible sur\u00a0: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22351650."},{"key":"10.1016\/j.pneumo.2012.12.003_bib0055","first-page":"1","article-title":"Non-asbestos related diffuse malignant mesothelioma","volume":"88","author":"Huncharek","year":"2002","journal-title":"Tumori"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0060","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1634\/theoncologist.12-10-1215","article-title":"Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002)","volume":"12","author":"Fasola","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCP.0b013e32812144bb","article-title":"Biomarkers for mesothelioma","volume":"13","author":"Scherpereel","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0070","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.200802-258OC","article-title":"Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study","volume":"178","author":"Park","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0080","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2169\/naika.100.2259","article-title":"Case report; malignant peritoneal mesothelioma with hypoglycemia suggestive of paraneoplastic syndrome","volume":"100","author":"Tozawa","year":"2011","journal-title":"Nippon Naika Gakkai Zasshi"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajcp\/82.1.15","article-title":"Diffuse malignant mesothelioma of pleura: diagnostic criteria based on an autopsy study","volume":"82","author":"Adams","year":"1984","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0095","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2214\/ajr.154.3.2106209","article-title":"CT in differential diagnosis of diffuse pleural disease","volume":"154","author":"Leung","year":"1990","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/crad.2000.0573","article-title":"Thoracic computed tomography in patients with suspected malignant pleural effusions","volume":"56","author":"Traill","year":"2001","journal-title":"Clin Radiol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0720-048X(01)00426-0","article-title":"Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases","volume":"41","author":"Metintas","year":"2002","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.semtcvs.2009.06.011","article-title":"Current trends in radiologic management of malignant pleural mesothelioma","volume":"21","author":"Gill","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejrad.2008.02.004","article-title":"Malignant pleural mesothelioma: computed tomography and correlation with histology","volume":"70","author":"Seely","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0125","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1510\/icvts.2010.255901","article-title":"Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?","volume":"12","author":"Sharif","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1378\/chest.125.2.489","article-title":"Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging","volume":"125","author":"Duysinx","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-5223(03)00207-1","article-title":"Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma","volume":"126","author":"Flores","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0140","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1378\/chest.118.3.604","article-title":"MRI and CT in the differential diagnosis of pleural disease","volume":"118","author":"Hierholzer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0145","first-page":"502","article-title":"Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma","volume":"42","author":"Knuuttila","year":"2001","journal-title":"Acta Radiol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0150","series-title":"World Health Organization classification of tumours. Pathology and genetics. Tumours of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1378\/chest.111.1.106","article-title":"The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma","volume":"111","author":"Renshaw","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0160","first-page":"177","article-title":"New diagnostic markers for malignant pleural mesothelioma","volume":"95","author":"Grigoriu","year":"2008","journal-title":"Bull Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0165","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0170","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","article-title":"Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis","volume":"30","author":"Hollevoet","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0175","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1164\/rccm.200807-1125OC","article-title":"Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment","volume":"179","author":"Grigoriu","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0180","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2407-10-242","article-title":"Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients","volume":"10","author":"Raiko","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-5002(02)00180-0","article-title":"Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis","volume":"38","author":"Berghmans","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0190","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"van Meerbeeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0195","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0200","first-page":"CD005574","article-title":"Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma","volume":"1","author":"Green","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0205","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(08)60727-8","article-title":"Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial","volume":"371","author":"Muers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","article-title":"Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two-phase II trials","volume":"99","author":"Ceresoli","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0215","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/JTO.0b013e31817c73d6","article-title":"Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemona\u00efve patients with malignant pleural mesothelioma: results of the International Expanded Access Program","volume":"3","author":"Santoro","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0220","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/annonc\/mdm501","article-title":"Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)","volume":"19","author":"Castagneto","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2008.08.016","article-title":"Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?","volume":"64","author":"Li","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3816\/CLC.2010.n.005","article-title":"Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study","volume":"11","author":"Katirtzoglou","year":"2010","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0235","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/01243894-200607000-00002","article-title":"Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program","volume":"1","author":"J\u00e4nne","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0240","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/annonc\/mdi187","article-title":"Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma","volume":"16","author":"Manegold","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0245","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pneumo.2010.07.013","article-title":"Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005\u20132006)","volume":"66","author":"Margery","year":"2010","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0250","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2006.09.9887","article-title":"Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma","volume":"26","author":"Jassem","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0255","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.lungcan.2011.08.011","article-title":"Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey","volume":"75","author":"Zucali","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0260","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.lungcan.2007.08.031","article-title":"Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second-line treatment option","volume":"60","author":"Razak","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0265","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10147-010-0064-7","article-title":"Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed","volume":"15","author":"Hayashi","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/COC.0b013e3181cae90e","article-title":"Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study","volume":"34","author":"Tourkantonis","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0275","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/cncr.23337","article-title":"Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma","volume":"112","author":"Zucali","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0280","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1200\/JCO.2003.05.123","article-title":"Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study","volume":"21","author":"Fizazi","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0285","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.lungcan.2004.08.005","article-title":"Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma","volume":"47","author":"Fennell","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0295","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/path.824","article-title":"Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma","volume":"193","author":"Strizzi","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0300","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2011.41.5869","article-title":"Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine\/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma","volume":"30","author":"Kindler","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0305","unstructured":"Dowell JE, Dunphy FR, Taub RN, Gerber DE, Ngov L, Yan J, et al. A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma. Lung cancer (Amsterdam, Netherlands) [Internet]. 2012\u00a0juillet 4 [cit\u00e9 2012\u00a0juillet 16]\u00a0; disponible sur\u00a0: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22770372."},{"key":"10.1016\/j.pneumo.2012.12.003_bib0310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1183\/09031936.00037310","article-title":"Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study","volume":"37","author":"Scherpereel","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0315","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1158\/1078-0432.CCR-07-0869","article-title":"Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus IV infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers","volume":"13","author":"Hassan","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0320","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1158\/1078-0432.CCR-06-0346","article-title":"Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice","volume":"12","author":"Zhang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0325","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-642-10862-4_7","article-title":"Surgical therapy of mesothelioma","volume":"189","author":"Rice","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0330","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(11)70307-2","article-title":"The MARS feasibility trial: conclusions not supported by data","volume":"12","author":"Weder","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0335","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extrapleural pneumonectomy versus no extrapleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0340","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11864-011-0146-4","article-title":"The evolution of multimodality therapy for malignant pleural mesothelioma","volume":"12","author":"Zauderer","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0345","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/JTO.0b013e31824ab6c5","article-title":"Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma","volume":"7","author":"Lang-Lazdunski","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0350","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.lungcan.2005.03.024","article-title":"Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma","volume":"49","author":"Ris","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0355","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.athoracsur.2011.02.062","article-title":"Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma","volume":"91","author":"Friedberg","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0360","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","article-title":"Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy","volume":"108","author":"Boutin","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjc.6601957","article-title":"A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma","volume":"91","author":"Bydder","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0370","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2007.05.022","article-title":"A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma","volume":"84","author":"O\u2019Rourke","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0375","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.semtcvs.2009.06.009","article-title":"Radiation therapy options for malignant pleural mesothelioma","volume":"21","author":"Baldini","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0380","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ijrobp.2007.02.047","article-title":"Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy","volume":"68","author":"Allen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0385","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0390","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijrobp.2007.03.011","article-title":"Dosedependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"69","author":"Rice","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0395","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","article-title":"Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"83","author":"Rosenzweig","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0400","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2011.09.025","article-title":"Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multiinstitutional series","volume":"101","author":"Tonoli","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0405","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/cbt.10.5.12616","article-title":"Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma","volume":"10","author":"Du","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0410","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.canrad.2010.06.010","article-title":"Which intensity modulated radiation therapy? From \u201cstep and shoot\u201d to volumetric modulated arc therapy, point of view of the radiation oncologist","volume":"14","author":"Vieillot","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.pneumo.2012.12.003_bib0415","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1118\/1.4735684","article-title":"SU-E-T-595. Comparison of Volumetric Modulated Arc Therapy (VMAT) and Static Intensity Modulated Radiotherapy (IMRT) for malignant pleural mesothelioma in patients with intact lungs\/post pleurectomy","volume":"39","author":"Dumane","year":"2012","journal-title":"Med Phys"}],"container-title":["Revue de Pneumologie Clinique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761841712001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761841712001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:15:23Z","timestamp":1760105723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761841712001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0761841712001526"],"URL":"https:\/\/doi.org\/10.1016\/j.pneumo.2012.12.003","relation":{},"ISSN":["0761-8417"],"issn-type":[{"value":"0761-8417","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge diagnostique et th\u00e9rapeutique du m\u00e9soth\u00e9liome pleural malin","name":"articletitle","label":"Article Title"},{"value":"Revue de Pneumologie Clinique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneumo.2012.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}